AgingResearch.NewsJoin free

No phaseNot yet recruiting

1-Month Versus 6-Month Dual Antiplatelet Therapy After Successful Drug-Coated Balloon-Only Percutaneous Coronary Intervention (ADAPT-DCB)

Sponsor
Ulsan University Hospital (Academic or other)
Enrolment
1,258 planned
Conditions
Coronary Artery Disease (CAD)
Interventions
1-Month DAPT; 6-Month DAPT
Ages
adults, older adults
Registry
NCT07879430

Full record on ClinicalTrials.gov

From the registry

This study will compare the clinical outcomes of a 1-month dual antiplatelet therapy (DAPT) strategy with a standard 6-month DAPT strategy in patients undergoing successful drug-coated balloon-only percutaneous coronary intervention (DCB-only PCI). The study will evaluate net adverse clinical events (NACE) at 12 months to assess whether short-term 1-month DAPT is non-inferior to 6-month DAPT. The study is a prospective, randomized, open-label, blinded-endpoint, multicenter trial.

Primary outcomes

  • NACE: at 12 Months

History

  1. Study completion expected

  2. Primary completion expected

  3. Expected to start

  4. Registered